Cervicitis: Difference between revisions

Jump to navigation Jump to search
Michael Maddaleni (talk | contribs)
Michael Maddaleni (talk | contribs)
Line 31: Line 31:
==Treatment==
==Treatment==
[[Cervicitis medical therapy|Medical therapy]] | [[Cervicitis surgery|Surgical options]] | [[Cervicitis primary prevention|Primary prevention]]  | [[Cervicitis secondary prevention|Secondary prevention]] | [[Cervicitis cost-effectiveness of therapy|Financial costs]] | [[Cervicitis future or investigational therapies|Future therapies]]
[[Cervicitis medical therapy|Medical therapy]] | [[Cervicitis surgery|Surgical options]] | [[Cervicitis primary prevention|Primary prevention]]  | [[Cervicitis secondary prevention|Secondary prevention]] | [[Cervicitis cost-effectiveness of therapy|Financial costs]] | [[Cervicitis future or investigational therapies|Future therapies]]
==Mucopurulent cervicitis==
'''Mucopurulent cervicitis''' (MPC) is characterized by a [[purulent]] or mucopurulent endocervical exudate visible in the endocervical canal or in an endocervical swab specimen. Some specialists also diagnose MPC on the basis of easily induced cervical bleeding. Although some specialists consider an increased number of [[polymorphonuclear leukocytes]] on endocervical Gram stain as being useful in the diagnosis of MPC, this criterion has not been standardized, has a low positive-predictive value (PPV), and is not available in some settings. MPC often is asymptomatic, but some women have an abnormal vaginal discharge and vaginal bleeding (e.g., after [[sexual intercourse]]). MPC can be caused by [[C. trachomatis]] or [[N. gonorrheae]]; however, in most cases neither organism can be isolated. MPC can persist despite repeated courses of antimicrobial therapy. Because relapse or reinfection with C. trachomatis or N. gonorrhoeae usually does not occur in persons with persistent cases of MPC, other non-microbiologic determinants (e.g., inflammation in the zone of ectopy) might be involved.
Patients who have MPC should be tested for [[C. trachomatis]] and for [[N. gonorrhoeae]] with the most sensitive and specific test available. However, MPC is not a sensitive predictor of infection with these organisms; most women who have C. trachomatis or N. gonorrhoeae do not have MPC.
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 14:39, 27 January 2012

For patient information, click here Template:DiseaseDisorder infobox

Cervicitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cervicitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cervicitis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cervicitis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cervicitis

CDC on Cervicitis

Cervicitis in the news

Blogs on Cervicitis

Directions to Hospitals Treating Cervicitis

Risk calculators and risk factors for Cervicitis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Causes

Differentiating Cervicitis

Complications & Prognosis

Diagnosis

History and Symptoms | Physical Examination | Staging | Laboratory tests | Electrocardiogram | X Rays | CT | MRI Echocardiography or Ultrasound | Other images | Alternative diagnostics

Treatment

Medical therapy | Surgical options | Primary prevention | Secondary prevention | Financial costs | Future therapies

References

Additional Resources

  • Centers for Disease Control and Prevention. Diseases characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2002 10 May; 51 (RR-6):30-42.
  • Much of an earlier version of this article was taken from the public domain document "Diseases characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines 2002." which can be found at http://www.guideline.gov/summary/summary.aspx?doc_id=3236

Template:STD/STI


Template:WikiDoc Sources